Vicki A. Morrison
University of Minnesota
USA
Name/email consistency: high
- Myeloid growth factors: to use or not to use, that is the question. Morrison, V. Leuk. Lymphoma (2006)
- Caspofungin: an overview. Morrison, V.A. Expert. Rev. Anti. Infect. Ther (2005)
- Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. Morrison, V.A., Rai, K.R., Peterson, B.L., Kolitz, J.E., Elias, L., Appelbaum, F.R., Hines, J.D., Shepherd, L., Larson, R.A., Schiffer, C.A. J. Clin. Oncol. (2002)
- The role of caspofungin and the echinocandins in the antifungal armamentarium. Morrison, V.A. Curr. Opin. Investig. Drugs (2002)
- Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011. Morrison, V.A., Rai, K.R., Peterson, B.L., Kolitz, J.E., Elias, L., Appelbaum, F.R., Hines, J.D., Shepherd, L., Martell, R.E., Larson, R.A., Schiffer, C.A. J. Clin. Oncol. (2001)
- The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin's lymphoma receiving initial CHOP chemotherapy: a risk factor analysis. Morrison, V.A., Picozzi, V., Scott, S., Pohlman, B., Dickman, E., Lee, M., Lawless, G., Kerr, R., Caggiano, V., Delgado, D., Fridman, M., Ford, J., Carter, W.B. Clin. Lymphoma (2001)
- Update on prophylaxis and therapy of infection in patients with chronic lymphocytic leukemia. Morrison, V.A. Expert. Rev. Anticancer. Ther (2001)